# Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia

> **NCT02521168** · PHASE3 · COMPLETED · sponsor: **National Cardiovascular Center Harapan Kita Hospital Indonesia** · enrollment: 177 (actual)

## Conditions studied

- Postoperative; Dysfunction Following Cardiac Surgery

## Interventions

- **DRUG:** Oral triiodothyronine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02521168
- **Lead sponsor:** National Cardiovascular Center Harapan Kita Hospital Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-10
- **Final completion:** 2015-01
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2016-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02521168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02521168, "Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02521168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*